|
1
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2013. CA Cancer J Clin. 63:11–30. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hu N, Wang Z, Song X, Wei L, Kim BS,
Freedman ND, Baek J, Burdette L, Chang J, Chung C, et al:
Genome-wide association study of gastric adenocarcinoma in Asia: A
comparison of associations between cardia and non-cardia tumours.
Gut. 65:1611–1688. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Nakajima T: Gastric cancer treatment
guidelines in Japan. Gastric Cancer. 5:1–5. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Vogiatzi P, Vindigni C, Roviello F,
Renieri A and Giordano A: Deciphering the underlying genetic and
epigenetic events leading to gastric carcinogenesis. J Cell
Physiol. 211:287–295. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Crew KD and Neugut AI: Epidemiology of
gastric cancer. World J Gastroenterol. 12:354–362. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Costa FF: Non-coding RNAs: Meet thy
masters. Bioessays. 32:599–608. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Liu J, Shen L, Yao J, Li Y, Wang Y, Chen H
and Geng P: Forkhead box C1 promoter upstream transcript, a novel
long non-coding RNA, regulates proliferation and migration in
basal-like breast cancer. Mol Med Rep. 11:3155–3159.
2015.PubMed/NCBI
|
|
8
|
Tian F, Tang Z, Song G, Pan Y, He B, Bao Q
and Wang S: Loss of imprinting of IGF2 correlates with
hypomethylation of the H19 differentially methylated region in the
tumor tissue of colorectal cancer patients. Mol Med Rep.
5:1536–1540. 2012.PubMed/NCBI
|
|
9
|
Eades G, Wolfson B, Zhang Y, Li Q, Yao Y
and Zhou Q: lincRNA-RoR and miR-145 regulate invasion in
triple-negative breast cancer via targeting ARF6. Mol Cancer Res.
13:330–338. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Rusek AM, Abba M, Eljaszewicz A, Moniuszko
M, Niklinski J and Allgayer H: MicroRNA modulators of epigenetic
regulation, the tumor microenvironment and the immune system in
lung cancer. Mol Cancer. 14:342015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Cheng CJ, Bahal R, Babar IA, Pincus Z,
Barrera F, Liu C, Svoronos A, Braddock DT, Glazer PM, Engelman DM,
et al: MicroRNA silencing for cancer therapy targeted to the tumour
microenvironment. Nature. 518:107–110. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kong R, Zhang EB, Yin DD, You LH, Xu TP,
Chen WM, Xia R, Wan L, Sun M, Wang ZX, et al: Long noncoding RNA
PVT1 indicates a poor prognosis of gastric cancer and promotes cell
proliferation through epigenetically regulating p15 and p16. Mol
Cancer. 14:822015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Pang Q, Ge J, Shao Y, Sun W, Song H, Xia
T, Xiao B and Guo J: Increased expression of long intergenic
non-coding RNA LINC00152 in gastric cancer and its clinical
significance. Tumour Biol. 35:5441–5447. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang CY, Hua L, Yao KH, Chen JT, Zhang JJ
and Hu JH: Long non-coding RNA CCAT2 is up-regulated in gastric
cancer and associated with poor prognosis. Int J Clin Exp Pathol.
8:779–785. 2015.PubMed/NCBI
|
|
15
|
Gan L, Xu M, Zhang Y, Zhang X and Guo W:
Focusing on long noncoding RNA dysregulation in gastric cancer.
Tumour Biol. 36:129–141. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhou B, Jing XY, Wu JQ, Xi HF and Lu GJ:
Down-regulation of long non-coding RNA LET is associated with poor
prognosis in gastric cancer. Int J Clin Exp Pathol. 7:8893–8898.
2014.PubMed/NCBI
|
|
17
|
Strong VE, D'Amico TA, Kleinberg L and
Ajani J: Impact of the 7th Edition AJCC staging classification on
the NCCN clinical practice guidelines in oncology for gastric and
esophageal cancers. J Natl Compr Canc Netw. 11:60–66.
2013.PubMed/NCBI
|
|
18
|
Schmittgen TD and Livak KJ: Analyzing
real-time PCR data by the comparative C(T) method. Nat Protoc.
3:1101–1108. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li J, Tian H, Yang J and Gong Z: Long
Noncoding RNAs regulate cell growth, proliferation, and apoptosis.
DNA Cell Biol. 35:459–470. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yamamoto H, Watanabe Y, Maehata T, Morita
R, Yoshida Y, Oikawa R, Ishigooka S, Ozawa S, Matsuo Y, Hosoya K,
et al: An updated review of gastric cancer in the next-generation
sequencing era: Insights from bench to bedside and vice versa.
World J Gastroenterol. 20:3927–3937. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Smith MG, Hold GL, Tahara E and El-Omar
EM: Cellular and molecular aspects of gastric cancer. World J
Gastroenterol. 12:2979–2990. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Szczesniak MW and Makalowska I: lncRNA-RNA
interactions across the human transcriptome. PLoS One.
11:e01503532016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Liu B, Sun L and Song E: Pinched by RNA
‘fingers’: Long noncoding RNAs hitting signal transduction
pathways. Mol Cell Oncol. 3:e10465822016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Li H, An J, Wu M, Zheng Q, Gui X, Li T, Pu
H and Lu D: LncRNA HOTAIR promotes human liver cancer stem cell
malignant growth through downregulation of SETD2. Oncotarget.
6:27847–27864. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Salameh A, Lee AK, Cardó-Vila M, Nunes DN,
Efstathiou E, Staquicini FI, Dobroff AS, Marchiò S, Navone NM,
Hosoya H, et al: PRUNE2 is a human prostate cancer suppressor
regulated by the intronic long noncoding RNA PCA3. Proc Natl Acad
Sci USA. 112:8403–8408. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhang H, Zhao L, Wang YX, Xi M, Liu SL and
Luo LL: Long non-coding RNA HOTTIP is correlated with progression
and prognosis in tongue squamous cell carcinoma. Tumour Biol.
36:8805–8809. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Liu L, Liu Y, Zhuang C, Xu W, Fu X, Lv Z,
Wu H, Mou L, Zhao G, Cai Z and Huang W: Inducing cell growth arrest
and apoptosis by silencing long non-coding RNA PCAT-1 in human
bladder cancer. Tumour Biol. 36:7685–7689. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Jiang S, Wang HL and Yang J: Low
expression of long non-coding RNA LET inhibits carcinogenesis of
cervical cancer. Int J Clin Exp Pathol. 8:806–811. 2015.PubMed/NCBI
|
|
29
|
Ma MZ, Kong X, Weng MZ, Zhang MD, Qin YY,
Gong W, Zhang WJ and Quan ZW: Long non-coding RNA-LET is a positive
prognostic factor and exhibits tumor-suppressive activity in
gallbladder cancer. Mol Carcinog. 54:1397–1406. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yang F, Huo XS, Yuan SX, Zhang L, Zhou WP,
Wang F and Sun SH: Repression of the long noncoding RNA-LET by
histone deacetylase 3 contributes to hypoxia-mediated metastasis.
Mol Cell. 49:1083–1096. 2013. View Article : Google Scholar : PubMed/NCBI
|
